Following an FDA marketing…
Following an FDA marketing suspension, Valneva has decided to voluntarily [...]
Following an FDA marketing suspension, Valneva has decided to voluntarily [...]
A study by the financial firm Jefferies highlights a surprising [...]
Robert G. Kramer sold nearly 90,000 shares of his stock [...]
Just days after AbbVie unveiled a major new oncology play [...]
With Fujifilm Biotechnologies now among the top echelon of CDMOs [...]
For the fourth year running—and the third in a row [...]
Exelixis may only have one drug on the market right [...]
The long-awaited plan would leave much to Congress and calls [...]
On this episode of “The Top Line,” we dig into [...]
New York’s attorney general has filed an insider trading lawsuit [...]